Differential survival impact of acetaminophen and non-steroidal anti-inflammatory drugs on NSCLC patients undergoing immune checkpoint inhibitor therapy: a region-wide cohort study in Hong Kong, China.

Saved in:
Bibliographic Details
Title: Differential survival impact of acetaminophen and non-steroidal anti-inflammatory drugs on NSCLC patients undergoing immune checkpoint inhibitor therapy: a region-wide cohort study in Hong Kong, China.
Authors: Wang SC; Department of Clinical Oncology, Hong Kong University Shenzhen Hospital, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China.; Department of Thoracic Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China., Ye ZH; Department of Clinical Oncology, Hong Kong University Shenzhen Hospital, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China.; Department of Thoracic Surgery, Jiangmen Centre Hospital, Jiangmen, China., Zhou H; Department of Radiation Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China., Zhao ZR; State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, and Department of Thoracic Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, China., Zhou YH; State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, and Department of Thoracic Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, China., Huang SJ; Department of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China., Gao Z; Centre of Cancer Cell and Molecular Biology, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, UK., Zhou ZH; Department of Thoracic Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China., Zheng DY; Department of Clinical Oncology, Hong Kong University Shenzhen Hospital, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China., Meng YN; Department of Clinical Oncology, Hong Kong University Shenzhen Hospital, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China., Lee TTL; Department of Emergency Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong, China., Wai AKC; Department of Emergency Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong, China., Kong FS; Department of Clinical Oncology, Hong Kong University Shenzhen Hospital, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China.; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
Source: Journal of the National Cancer Center [J Natl Cancer Cent] 2026 Feb 15; Vol. 6 (2), pp. 185-188. Date of Electronic Publication: 2026 Feb 15 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 9918334970706676 Publication Model: eCollection Cited Medium: Internet ISSN: 2667-0054 (Electronic) Linking ISSN: 26670054 NLM ISO Abbreviation: J Natl Cancer Cent Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2667-0054
DOI:10.1016/j.jncc.2026.02.003